Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program

Ixazomib-Revlimid-Dexamethasone is an all-oral treatment protocol for multiple myeloma with a manageable tolerability profile which was available through a named patient program for Hungarian patients from December 2015 to April 2017. We analyzed the clinical characteristics and survival of 77 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Varga, Gergely, Nagy, Zsolt, Demeter, Judit, Kosztolányi, Szabolcs, Szomor, Árpád, Alizadeh, Hussain, Deák, Beáta, Schneider, Tamás, Plander, Márk, Szendrei, Tamás, Váróczy, László, Illés, Árpád, Bátai, Árpád, Pető, Mónika, Mikala, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815275/
https://www.ncbi.nlm.nih.gov/pubmed/30712192
http://dx.doi.org/10.1007/s12253-019-00607-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815275/
https://www.ncbi.nlm.nih.gov/pubmed/30712192
http://dx.doi.org/10.1007/s12253-019-00607-2

Ejemplares similares